M&A Deal Summary |
|
|---|---|
| Date | 2018-01-05 |
| Target | Vita Liberata |
| Sector | Consumer Products |
| Buyer(s) | Crown Laboratories |
| Deal Type | Add-on Acquisition |
| Advisor(s) | The Sage Group (Financial) Tughans (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
Crown Laboratories is a specialty pharmaceutical company that produces medical products such as Blue Lizard Australian Sunscreen and medical products AlaQuin, AlaScalp, and Daxbia. Crown Laboratories currently operates three distinct areas of focus related to skincare and treating skin-related conditions: Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. Crown Laboratories was founded in 2000 and is based in Johnson City, Tennessee.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 8 |
| Sector: Consumer Products M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 5 |
| State: Tennessee M&A | 1 of 1 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-27 |
Crown Aesthetics
Dallas, Texas, United States Crown Aesthetics is a medical aesthetics treatments company dedicated to delivering innovative repair and restoration products to aesthetic practices around the world. Bellus’s non-invasive products give it a unique position in aesthetics, providing a range of products that draw first-time consumers to leading physician-directed practices globally. Most notable among its products is the SkinPen – a medical-grade micro-needling device used exclusively by healthcare professionals to improve the appearance of facial acne scars – the first micro-needling device in the industry to be granted clearance and marketing authorization by the U.S. Food and Drug Administration (FDA) for this indication. Crown Aesthetics was founded in 2012 and is based in Dallas, Texas. |
Buy | - |
